
    
      This trial will be a triple-blind, double-dummy, prospective, multicenter, randomized
      clinical trial comparing the effectiveness of OSB-IR to the effectiveness of intravenous
      cimetidine in preventing upper GI bleeding at risk for SRMD.
    
  